Re: I think one major reason that,
in response to
by
posted on
Nov 01, 2019 04:37PM
The phase 2 data is derived from a small patient group. Phase 3 (BOM) data is from a much larger patient group and all patients with diabetes. Perhaps FDA felt that may get different results.
Koo